Kyverna Therapeutics, Inc. (KYTX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Kyverna Therapeutics, Inc. (KYTX) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

KYTX Income Statement

Kyverna Therapeutics, Inc. (KYTX) annual income statement — 5-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	351K	0	0	515K	501K	563K	29.19M	0	22.48K	17.16M	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-351K	0	0	-515K	-501K	-563K	-29.19M	0	-22.48K	-17.16M	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	100%	29.94%	100%	100%	-	-2129.04%	96.72%	-	-	-	-	-	-
Operating Expenses	39.56M	41.02M	39.28M	38.73M	43.9M	46.91M	40.48M	9.58M	33.44M	6.88K	4.21M	16.28M	13.3M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	14.77M	11.29M	9.27M	8.27M	8.59M	9.97M	7.56M	7.88M	6.11M	5.78K	4.21M	2.64M	2.9M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	24.79M	29.72M	30.01M	30.46M	35.82M	37.43M	32.92M	29.19M	27.32M	22.48K	17.16M	13.64M	10.4M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	-515K	-501K	0	-1000K	0	-21.38K	-1000K	0	0
Operating Income	-39.56M	-41.37M	-39.28M	-38.73M	-44.41M	-47.41M	-41.04M	-38.77M	-33.44M	-29.36K	-21.38M	-16.28M	-13.3M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	10.93%	12.74%	4.29%	0.11%	-32.82%	-161382.39%	-91.99%	-138.12%	-151.35%	-	-	-	-
EBITDA	-39.54M	-41.02M	-38.91M	-38.31M	-43.9M	-46.91M	-40.48M	-38.45M	-32.91M	-29.11K	-21.15M	-15.84M	-12.89M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	9.93%	12.56%	3.86%	0.36%	-33.4%	-161020.46%	-91.42%	-142.67%	-155.3%	-	-	-	-
D&A (Non-Cash Add-back)	0	351K	368K	415K	515K	501K	563K	321K	530K	245	231K	438K	413K
EBIT	-39.54M	-39.06M	-37.36M	-36.78M	-42.07M	-44.61M	-37.46M	-37.07M	-28.76M	-28.26K	-21.38M	-15.41M	-13.04M
Net Interest Income	1.25M	1.66M	1.46M	1.99M	2.35M	2.8M	3.55M	4.32M	4.66M	2.69M	742K	830K	218K
Interest Income	1.93M	2.33M	1.91M	2M	2.36M	2.83M	3.58M	4.36M	4.69M	2.73M	789K	880K	264K
Interest Expense	674K	667K	444K	7K	14K	25K	27K	32K	39K	44K	47K	50K	46K
Other Income/Expense	1.24M	1.64M	1.48M	1.94M	2.33M	2.77M	3.55M	4.28M	4.63M	2.67K	710K	817K	211K
Pretax Income	-38.32M	-39.73M	-37.8M	-36.79M	-42.08M	-44.63M	-37.49M	-34.49M	-28.8M	-26.69K	-20.67M	-15.46M	-13.09M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-38.32M	-39.73M	-37.8M	-36.79M	-42.08M	-44.63M	-37.49M	-34.49M	-28.8M	-26.69K	-20.67M	-15.46M	-13.09M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	8.94%	10.99%	-0.84%	-6.65%	-46.1%	-167116.12%	-81.4%	-123.03%	-120.02%	-	-	-	-
Net Income (Continuing)	-38.32M	-39.73M	-37.8M	-36.79M	-42.08M	-44.63M	-37.49M	-34.49M	-28.8M	-26.69K	-20.67M	-15.46M	-13.09M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.63	-0.66	-0.80	-0.85	-0.97	-1.03	-0.87	-0.80	-0.67	-1.12	-0.48	-0.36	-0.30
EPS Growth %	35.05%	35.92%	8.05%	-6.25%	-44.78%	8.04%	-81.25%	-122.22%	-123.33%	-	-	-	-
EPS (Basic)	-0.63	-0.66	-0.80	-0.85	-0.97	-1.03	-0.87	-0.80	-0.67	-1.12	-0.48	-0.36	-0.30
Diluted Shares Outstanding	60.9M	60.43M	47.16M	43.42M	43.23M	43.22M	43.21M	43.16M	43.13M	23.75M	43.12M	43.12M	43.12M
Basic Shares Outstanding	60.9M	60.43M	47.16M	43.42M	43.23M	43.22M	43.21M	43.16M	43.13M	23.75M	43.12M	43.12M	43.12M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-